台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效

健亞

(4130)
可現股當沖
  • 股價
    24.35
  • 漲跌
    ▲0.30
  • 漲幅
    +1.25%
  • 成交量
    241
  • 產業
    上櫃 生技醫療類股
  • 150人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
健亞 (4130)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/17     後一日»

券商獲利排行 - 2024/04/17

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  0.41%1.501.51515024.324.3024.4
  1.13%1.11.1004424.424.224.524.4
  0.24%11.2-0.2-991824.324.224.324.4
  0.41%1011010024.324.3024.4
  0.26%0.900.91214224.324.324.324.4
  0.62%0.900.966024.224.2024.4
  0.55%0.800.866024.224.2024.4
  0.62%0.800.855024.224.2024.4
  0.62%0.800.855024.224.2024.4
  0.33%0.60.40.2-44824.424.324.424.4
  0.25%0.600.61010024.324.3024.4
  0.62%0.600.644024.224.2024.4
  1.03%0.50.5002224.424.324.524.4
  1.01%0.50.5002224.424.324.524.4
  0.31%0.500.566024.324.3024.4
  0.55%0.400.423124.224.224.224.4
  1.23%0.30.3001124.424.224.524.4
  0.61%0.300.3-20224.5024.524.4
  0.11%0.30.6-0.3-741124.324.224.324.4
  0.41%0.200.222024.324.3024.4
  0.83%0.200.211024.224.2024.4
  0.83%0.200.211024.224.2024.4
  0.21%0.200.233024.324.3024.4
  0.21%0.200.223024.324.324.524.4
  0.62%0.200.211024.224.2024.4
  0.62%0.200.211024.224.2024.4
  0.62%0.200.211024.224.2024.4
  0.62%0.200.211024.224.2024.4
  0.62%0.200.211024.224.2024.4
  0.62%0.100.111024.224.2024.4
  0.05%0.100.188024.324.3024.4
  0.21%0.100.112124.324.324.324.4
  0.41%0.100.111024.324.3024.4
  0.41%0.100.111024.324.3024.4
  0.41%0.100.111024.324.3024.4
  0.41%0.100.111024.324.3024.4
  0.28%0.100.111024.324.324.424.4
  0.21%0.100.111024.324.3024.4
  0.21%0.100.111024.324.3024.4
  0.21%0.100.111024.324.3024.4
  0.21%0.100.111024.324.3024.4
  0.21%0.100.111024.324.3024.4
  0.07%00.2-0.1-21324.324.224.324.4
   00000024.224.2024.4
   00000024.224.2024.4
   00000024.2024.224.4
   00000024.3024.324.4
   00000024.3024.324.4
   00000024.5024.524.4
   00000024.2024.224.4

券商虧損排行 - 2024/04/17

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.19%-5.8-5.800202024.424.524.224.4
  -0.62%-30-3-1902024.224.324.224.4
  -0.55%-2.70-2.7-2002024.2024.224.4
  -0.83%-1.20-1.2-60624.2024.224.4
  -0.41%-10-1-1001024.3024.324.4
  -0.55%-0.40-0.4-30324.2024.224.4
  -0.21%-0.30-0.3-60624.3024.324.4
  -0.21%-0.30-0.3-60624.3024.324.4
  -0.21%-0.30-0.3-50524.3024.324.4
  -0.41%-0.20-0.2-20224.3024.324.4
  -0.21%-0.20-0.2-30324.3024.324.4
  -0.62%-0.20-0.2-10124.2024.224.4
  -0.43%-0.10-0.1-10124.2024.224.4
  -0.41%-0.10-0.1-10124.3024.324.4
  -0.41%-0.10-0.1-10124.3024.324.4
  -0.41%-0.10-0.1-10124.3024.324.4
  -0.21%-0.10-0.1-10124.3024.324.4
  -0.21%-0.10-0.1-10124.3024.324.4
  -0.21%-0.10-0.1-10124.3024.324.4
  -0.21%-0.10-0.1-10124.3024.324.4
  -0.21%-0.10-0.1-10124.3024.324.4
  -0.21%-0.10-0.1-10124.3024.324.4
   00000024.2024.224.4
   00000024.424.4024.4
   00000024.2024.224.4
   00000024.2024.224.4
   00000024.224.2024.4
   00000024.2024.224.4
   00000024.3024.324.4
   00000024.4024.424.4
   00000024.2024.224.4
   00000024.3024.324.4
   00000024.224.2024.4
   00000024.224.2024.4
   00000024.3024.324.4
   00000024.5024.524.4
   00000024.3024.324.4
   00000024.4024.424.4
   00000024.324.424.224.4
   00000024.2024.224.4
   00000024.5024.524.4
   00000024.3024.324.4
   00000024.224.2024.4
  0.07%00.2-0.1-21324.324.224.324.4
  0.21%0.100.111024.324.3024.4
  0.21%0.100.111024.324.3024.4
  0.21%0.100.111024.324.3024.4
  0.21%0.100.111024.324.3024.4
  0.21%0.100.111024.324.3024.4
  0.28%0.100.111024.324.324.424.4
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨-2022/09/12
健亞 相關文章